Cargando…

Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study

INTRODUCTION: Hepatotoxicity is one of the risk factors associated with treatment non-adherence, which is the main risk factor for drug resistance. Therefore, this study aimed to determine the incidence and risk factors of hepatotoxicity during highly active antiretroviral therapy (HAART) among peop...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebremicael, Gebremedhin, Tola, Habteyes Hailu, Gebreegziaxier, Atsbeha, Kassa, Desta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006948/
https://www.ncbi.nlm.nih.gov/pubmed/33790657
http://dx.doi.org/10.2147/HIV.S283076
_version_ 1783672397602226176
author Gebremicael, Gebremedhin
Tola, Habteyes Hailu
Gebreegziaxier, Atsbeha
Kassa, Desta
author_facet Gebremicael, Gebremedhin
Tola, Habteyes Hailu
Gebreegziaxier, Atsbeha
Kassa, Desta
author_sort Gebremicael, Gebremedhin
collection PubMed
description INTRODUCTION: Hepatotoxicity is one of the risk factors associated with treatment non-adherence, which is the main risk factor for drug resistance. Therefore, this study aimed to determine the incidence and risk factors of hepatotoxicity during highly active antiretroviral therapy (HAART) among people living with HIV in Ethiopia. METHODS: A prospective cohort study was conducted between April 2007 and January 2011 at Saint Peter Specialized Hospital, Akaki and Kality Health Centers, Addis Ababa, Ethiopia. A total of 316 HIV-infected adult individuals (70 participants were HIV and TB co-infected and 246 were infected with HIV alone) were included in this study. The study participants were followed for a total of 18 months with or without HAART. Socio-demographic data were collected using a structured questionnaire, and venous blood samples were collected for laboratory tests. Logistic regression and Poisson regression were used to determine the independent effect of each variable on hepatotoxicity at baseline and end of follow-up. RESULTS: Of 316 HIV-infected people, 72 (22.8%) participants had an elevated ALT/AST which was 100% mild-to moderate hepatotoxicity at baseline. Baseline CD4 T-cell count (p = 0.027) and HIV co-infection with TB (p < 0.001) were independently associated with hepatotoxicity at baseline. The overall incidence rate of hepatotoxicity in participants on HAART (21.8 per 100 person-years) was lower than participants who were HAART naïve (33.3 per 100 person-years) (p = 0.009). CONCLUSION: High incidence of mild-to-moderate hepatotoxicity and low severe hepatotoxicity were observed in HIV-infected individuals who were on HAART or were HAART naïve. HAART may minimize the occurrence of hepatotoxicity. Although HAART could minimize hepatotoxicity among HIV-infected people, to manage mild and moderate hepatotoxicity liver function test monitoring is required.
format Online
Article
Text
id pubmed-8006948
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-80069482021-03-30 Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study Gebremicael, Gebremedhin Tola, Habteyes Hailu Gebreegziaxier, Atsbeha Kassa, Desta HIV AIDS (Auckl) Original Research INTRODUCTION: Hepatotoxicity is one of the risk factors associated with treatment non-adherence, which is the main risk factor for drug resistance. Therefore, this study aimed to determine the incidence and risk factors of hepatotoxicity during highly active antiretroviral therapy (HAART) among people living with HIV in Ethiopia. METHODS: A prospective cohort study was conducted between April 2007 and January 2011 at Saint Peter Specialized Hospital, Akaki and Kality Health Centers, Addis Ababa, Ethiopia. A total of 316 HIV-infected adult individuals (70 participants were HIV and TB co-infected and 246 were infected with HIV alone) were included in this study. The study participants were followed for a total of 18 months with or without HAART. Socio-demographic data were collected using a structured questionnaire, and venous blood samples were collected for laboratory tests. Logistic regression and Poisson regression were used to determine the independent effect of each variable on hepatotoxicity at baseline and end of follow-up. RESULTS: Of 316 HIV-infected people, 72 (22.8%) participants had an elevated ALT/AST which was 100% mild-to moderate hepatotoxicity at baseline. Baseline CD4 T-cell count (p = 0.027) and HIV co-infection with TB (p < 0.001) were independently associated with hepatotoxicity at baseline. The overall incidence rate of hepatotoxicity in participants on HAART (21.8 per 100 person-years) was lower than participants who were HAART naïve (33.3 per 100 person-years) (p = 0.009). CONCLUSION: High incidence of mild-to-moderate hepatotoxicity and low severe hepatotoxicity were observed in HIV-infected individuals who were on HAART or were HAART naïve. HAART may minimize the occurrence of hepatotoxicity. Although HAART could minimize hepatotoxicity among HIV-infected people, to manage mild and moderate hepatotoxicity liver function test monitoring is required. Dove 2021-03-25 /pmc/articles/PMC8006948/ /pubmed/33790657 http://dx.doi.org/10.2147/HIV.S283076 Text en © 2021 Gebremicael et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Gebremicael, Gebremedhin
Tola, Habteyes Hailu
Gebreegziaxier, Atsbeha
Kassa, Desta
Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study
title Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study
title_full Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study
title_fullStr Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study
title_full_unstemmed Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study
title_short Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study
title_sort incidence of hepatotoxicity and factors associated during highly active antiretroviral therapy in people living with hiv in ethiopia: a prospective cohort study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006948/
https://www.ncbi.nlm.nih.gov/pubmed/33790657
http://dx.doi.org/10.2147/HIV.S283076
work_keys_str_mv AT gebremicaelgebremedhin incidenceofhepatotoxicityandfactorsassociatedduringhighlyactiveantiretroviraltherapyinpeoplelivingwithhivinethiopiaaprospectivecohortstudy
AT tolahabteyeshailu incidenceofhepatotoxicityandfactorsassociatedduringhighlyactiveantiretroviraltherapyinpeoplelivingwithhivinethiopiaaprospectivecohortstudy
AT gebreegziaxieratsbeha incidenceofhepatotoxicityandfactorsassociatedduringhighlyactiveantiretroviraltherapyinpeoplelivingwithhivinethiopiaaprospectivecohortstudy
AT kassadesta incidenceofhepatotoxicityandfactorsassociatedduringhighlyactiveantiretroviraltherapyinpeoplelivingwithhivinethiopiaaprospectivecohortstudy